Close Menu
Home › About Us › Our Staff › Ciara Curtin

Ciara Curtin

Editor, Daily Scan
Phone Number
+1-212-651-5627
Email
[email protected]

Ciara Curtin writes science features for GenomeWeb and is the editor of the Daily Scan and Careers blogs.

Articles Authored by Ciara Curtin

Jan 06, 2020

Organoids Fuel Development of Gene Expression Approach for Tailoring Pancreatic Cancer Treatment

Premium

The organoids could be grown to contain cellular features of the original tissue samples, enabling them to better mimic what occurs in the body than two-dimensional cultures.

Dec 03, 2019

Classification Algorithm Divides Pancreatic Cancer Patients by Likely Treatment Response, Outcome

Premium

The classifier, called PurIST, can be applied to various pancreatic cancer sample types and different gene expression platforms, which may improve its clinical applicability.

Nov 07, 2019

NSGC Panel Divided on Whether Newly Diagnosed Breast Cancer Patients Should Undergo Panel Testing

Premium

Genetic testing results increasingly inform clinical decisions, though the inclusion of hereditary risk genes beyond BRCA1, BRCA2, and PALB2 sparked debate.

Oct 29, 2019

Mayo Clinic Researchers Plan to Launch Trials for Preventative Breast Cancer Vaccine in 2020

Premium

The vaccine targets multiple proteins that are overexpressed by breast tumors and aims to prevent the disease from developing.

Oct 15, 2019

Tumor-Derived Organoids ID Colorectal Cancer Patients Who Don't Respond to Irinotecan-Based Chemo

Premium

The patient-derived organoids, though, couldn't predict response to a 5-fluorouracil plus oxaliplatin regimen, underscoring more research is needed before clinical use.

Sep 24, 2019

Certain BRAF Mutations May Indicate Tumors More Likely to Respond to Anti-EGFR Therapy

Premium

In a study, patients with class 3 BRAF mutations were more likely to respond to an anti-EGFR antibody treatment as a first-or second-line therapy.

Sep 23, 2019

Biomarker Research Advancing to Predict Small Cell Lung Cancer Treatment Response

Premium

Treatment biomarkers for small cell lung cancer have been nearly non-existent, but researchers are beginning to find ones that mark PARP inhibitor response.

Aug 21, 2019

New FDA Program May Help Oncologists Access Investigational Drugs in Precision Medicine Era

The program, called Project Facilitate, aims to help oncologists request access to investigational drugs but may only simplify part of the process.

Aug 13, 2019

Squamous Cell Lung Cancer Subtypes Point to Potential Therapeutic Approaches

Premium

A proteogenomic analysis by a Moffitt Cancer Center-led team uncovered three subtypes of squamous cell lung cancer and treatment approaches to investigate.

Jul 26, 2019

MSK Study Raises Questions About Pan-Cancer Potential of PARP Inhibitors

Premium

A finding that not all BRCA-mutated tumors are likely to respond to PARP inhibitors should make doctors more cautious when prescribing them off label.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.